Physician profile
Jonathan Lischalk
NPI 1083973556
$54,618.58
in general payments reported to CMS, 2019-2025
10 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,449 · 2020: $4,028 · 2021: $6,044 · 2022: $5,113 · 2023: $7,314 · 2024: $4,147 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Honoraria: $4,500 · Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,700.00 |
| Travel and Lodging | $10,483.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Honoraria | $4,500.00 |
| Food and Beverage | $800.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $53,658.26 | 2019-2025 | Cyberknife System, Tomo Therapy System |
| Boston Scientific Corporation | $474.48 | 2021-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Progenics Pharmaceuticals, INC. | $125.00 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.02 | 2019 | |
| Myovant Sciences INC. | $109.52 | 2022 | |
| Sumitomo Pharma America, INC. | $61.11 | 2024-2025 | Orgovyx |
| Palette Life Sciences, INC. | $22.91 | 2022 | |
| Electromed, INC. | $22.89 | 2023 | Smartvest |
| Novocure INC. | $17.72 | 2021 | |
| Mevion_medical_systems_inc | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lischalk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.